Citigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

Benzinga Newsdesk www.benzinga.com Positive 58.3%

Neg 0% Neu 0% Pos 58.3%

Citigroup analyst Daniel Grosslight maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $650 to $670.